Gujarat Kidney Seeks Shareholder Vote to Reroute IPO Funds for New Hospital

Gujarat Kidney And Superspeciality Limited is asking shareholders to approve rerouting ₹44.96 crore of its unspent Initial Public Offering (IPO) funds. The company raised ₹250.80 crore through its IPO in September 2022.

Key Proposals for Shareholder Vote

The company is holding a shareholder vote, using postal ballot and e-voting methods, on several key proposals. The most significant is a plan to change how its IPO proceeds are used. Gujarat Kidney aims to build a multi-speciality hospital in Bharuch and start dialysis services via a partnership. This plan differs significantly from the initial IPO objectives, which included establishing a women's hospital in Vadodara and purchasing advanced robotics equipment. Shareholders will also vote on voluntarily revising financial statements for fiscal years 2021-22, 2022-23, and 2023-24. Additionally, they will decide on appointing Dharmendra Bhaliya as the Secretarial Auditor for FY 2025-26. E-voting is open from March 27, 2026, to April 25, 2026.

Strategic Shift and Governance

The proposed shift in IPO fund use signals a significant strategic change for Gujarat Kidney, potentially altering its growth path and geographic priorities. Shareholder approval is essential, as any alteration to IPO objectives needs their clear consent. The company is also proposing to revise its financial statements for the past three fiscal years, reflecting a commitment to accurate reporting. Appointing a secretarial auditor is a standard step to ensure regulatory compliance.

IPO Background

Gujarat Kidney And Superspeciality Limited's IPO in September 2022 raised ₹250.8 crore. These funds were originally intended for establishing a women's hospital in Vadodara and acquiring medical robotics equipment. The current proposal indicates a reevaluation of these initial expansion plans.

Potential Risks

Building and running new hospitals often involve construction delays, approval difficulties, and coordination issues. Establishing dialysis services requires health authority approvals, navigating regulatory changes, and managing potential operational challenges. The new Bharuch facility might also see slower initial patient numbers and delayed investment returns.

Competitive Landscape

Major healthcare providers like Apollo Hospitals and Fortis Healthcare operate extensive multi-speciality hospital networks across India. KIMS Hospitals is also growing its multi-speciality services, highlighting a competitive environment for such expansions.

Key Figures

The company's IPO in September 2022 raised ₹250.80 crore. Currently, ₹44.96 crore of these funds are unutilized. The proposed allocation earmarks ₹30.10 crore for the Bharuch hospital and ₹6.83 crore for dialysis services.

Looking Ahead

Investors will be closely watching the outcome of the shareholder vote and the subsequent announcement of results. Key developments to track include the company's progress in implementing the revised IPO fund plan, the timeline for filing updated financial statements, the scope of work for the appointed secretarial auditor, and updates on the construction and launch of the new Bharuch hospital and dialysis services.